Skip to content
RDL Network logo
Tu1648 PROGNOSTIC IMPACT OF TYROSINE KINASE INHIBITOR SEQUENTIAL TREATMENT INCLUDING LENVATINIB FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA — Kanako Otsuka (2020) | RDL Network